Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

BUY
$26.26 - $29.9 $122,975 - $140,021
4,683 Added 274.66%
6,388 $168,000
Q1 2024

May 15, 2024

SELL
$27.46 - $31.33 $109,318 - $124,724
-3,981 Reduced 70.01%
1,705 $52,000
Q4 2023

Feb 14, 2024

BUY
$26.21 - $29.22 $149,030 - $166,144
5,686 New
5,686 $160,000

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $10.6B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track I A Global Asset Management Inc. Portfolio

Follow I A Global Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of I A Global Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on I A Global Asset Management Inc. with notifications on news.